Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

We examined whether plasma C-reactive protein (CRP) levels at the time of diagnosis of breast cancer are associated with overall survival, disease-free survival, death from breast cancer, and recurrence of breast cancer.
Original languageEnglish
JournalBreast Cancer Research (Online Edition)
Issue number3
Pages (from-to)R55
Publication statusPublished - 2011

ID: 40139117